Lisocabtagene Maraleucel (Liso-Cel) As Second-Line Treatment For R/R Large B-Cell Lymphoma (Lbcl) In Patients Not Intended For Hsct: Patient-Reported Outcomes (Pro) From The Phase 2 Pilot Study
Lisocabtagene Maraleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Lisocabtagene Maraleucel (Liso-Cel) As Second-Line Treatment For R/R Large B-Cell Lymphoma (Lbcl) In Patients Not Intended For Hsct: Patient-Reported Outcomes (Pro) From The Phase 2 Pilot Study ### Output: Lisocabtagene Maraleucel